Christopher Breunig studied molecular biology and biochemistry at the University of Bayreuth and the University of Edinburgh. From 2015 to 2019 he worked with Prof. Stefan Stricker and Prof. Magdalena Götz at the Helmholtz Center and the Biomedical Center in Munich which peaked in receiving a PhD from LMU. During this time, he developed and implemented novel CRISPR tools, to push the boundaries of this outstanding technology even further. These techniques found application in various publications all over the world. Christopher joined ISAR Bioscience and the Genome Engineering team in early 2020 as a scientist and leads the team since 2022. At ISAR Christopher is responsible for the genetic modification of cells and supports internal development of disease models and cell therapies, as well as customers and external collaborators.